Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.
about
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) miceLong-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST studyCorrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.Retinal angiomatous proliferation or retinal anastomosis to the lesion.Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation.Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration.[Therapy of stage III retinal angiomatous proliferation. Intravitreal ranibizumab injections].Visual and morphological outcomes of bevacizumab (Avastin®) versus ranibizumab (Lucentis®) treatment for retinal angiomatous proliferation.Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation.[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
P2860
Q33808187-1C67D388-99AC-46C6-A161-16F19C4356BCQ33886005-A5F87DEC-A626-4606-9338-D667162C15BEQ36008093-E981E931-2BE7-424F-AA5F-B44EDB84D903Q36219639-DCF2B284-5287-4FF9-A1AA-95EB7E7B4F50Q37658305-54433FF1-EC68-4A89-9E19-C56534A14452Q37986462-7906582E-6057-4525-85AA-1901DB7A24C4Q42204337-C01C5F08-9967-4D7A-A02B-D173C49341F1Q43030487-0C645B0C-82B0-41D1-A927-93F4E773B963Q43164512-7EC5AAC4-8CD8-4EC3-BFD1-E4F22ADA9624Q44345438-7F92A5C5-642B-4A1E-9A50-47D2DDA75A0DQ50498550-97252FD2-ED59-45E0-8039-F6FCEA05F81DQ50511227-5396C8C9-06B9-448F-AE73-C4CF8488A6A8Q50549303-5FB56806-598E-4726-A1F4-AA0787062080Q58697934-8A34B412-8956-4163-BEA5-C41E07D727E8
P2860
Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Ranibizumab for retinal angiom ...... -related macular degeneration.
@en
type
label
Ranibizumab for retinal angiom ...... -related macular degeneration.
@en
prefLabel
Ranibizumab for retinal angiom ...... -related macular degeneration.
@en
P1476
Ranibizumab for retinal angiom ...... e-related macular degeneration
@en
P2093
David T Liu
Wai-Man Chan
P2888
P304
P356
10.1007/S00417-007-0679-1
P577
2007-09-28T00:00:00Z